510 related articles for article (PubMed ID: 26755879)
1. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma.
Wang YG; Huang PP; Zhang R; Ma BY; Zhou XM; Sun YF
World J Gastroenterol; 2016 Jan; 22(1):326-37. PubMed ID: 26755879
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma.
Hadi M; Qutaiba B Allela O; Jabari M; Jasoor AM; Naderloo O; Yasamineh S; Gholizadeh O; Kalantari L
Virol J; 2024 Jan; 21(1):17. PubMed ID: 38216938
[TBL] [Abstract][Full Text] [Related]
3. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
[TBL] [Abstract][Full Text] [Related]
4. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
Chandler RJ; LaFave MC; Varshney GK; Trivedi NS; Carrillo-Carrasco N; Senac JS; Wu W; Hoffmann V; Elkahloun AG; Burgess SM; Venditti CP
J Clin Invest; 2015 Feb; 125(2):870-80. PubMed ID: 25607839
[TBL] [Abstract][Full Text] [Related]
5. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
8. Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.
Dhungel B; Jayachandran A; Layton CJ; Steel JC
Drug Deliv; 2017 Nov; 24(1):289-299. PubMed ID: 28165834
[TBL] [Abstract][Full Text] [Related]
9. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
10. Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.
Hu H; Qiu Y; Guo M; Huang Y; Fang L; Peng Z; Ji W; Xu Y; Shen S; Yan Y; Huang X; Zheng J; Su C
Oncotarget; 2015 Jan; 6(2):1079-89. PubMed ID: 25473902
[TBL] [Abstract][Full Text] [Related]
11. AAV Infection: Protection from Cancer.
Srivastava A; Carter BJ
Hum Gene Ther; 2017 Apr; 28(4):323-327. PubMed ID: 27832705
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus and adeno-associated virus mediated gene transfer.
Kremer EJ; Perricaudet M
Br Med Bull; 1995 Jan; 51(1):31-44. PubMed ID: 7767647
[TBL] [Abstract][Full Text] [Related]
13. An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells.
Yuan S; Fang X; Xu Y; Ni A; Liu XY; Chu L
Oncotarget; 2016 Sep; 7(37):60491-60502. PubMed ID: 27528029
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy strategies for hepatocellular carcinoma.
Hwang LH
J Biomed Sci; 2006 Jul; 13(4):453-68. PubMed ID: 16633742
[TBL] [Abstract][Full Text] [Related]
15. Image-aided Suicide Gene Therapy Utilizing Multifunctional hTERT-targeting Adenovirus for Clinical Translation in Hepatocellular Carcinoma.
Kim YH; Kim KT; Lee SJ; Hong SH; Moon JY; Yoon EK; Kim S; Kim EO; Kang SH; Kim SK; Choi SI; Goh SH; Kim D; Lee SW; Ju MH; Jeong JS; Kim IH
Theranostics; 2016; 6(3):357-68. PubMed ID: 26909111
[TBL] [Abstract][Full Text] [Related]
16. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
Huang F; Ma B; Wang Y; Xiao R; Kong Y; Zhou X; Xia D
Cancer Biother Radiopharm; 2014 Dec; 29(10):403-11. PubMed ID: 25414976
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
18. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
19. Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.
Della Peruta M; Badar A; Rosales C; Chokshi S; Kia A; Nathwani D; Galante E; Yan R; Arstad E; Davidoff AM; Williams R; Lythgoe MF; Nathwani AC
Hum Gene Ther; 2015 Feb; 26(2):94-103. PubMed ID: 25569358
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies for hepatitis B virus-associated hepatocellular carcinoma.
Wong ET; Chew YP; Lee LA; Lee CG
Curr Drug Targets; 2002 Oct; 3(5):369-78. PubMed ID: 12182228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
